Clinical Trial Update: The Impact of Nafamostat Mesylate on the Prognosis of Patients With Sepsis-Induced Coagulopathy Undergoing Hemofiltration [NA]

View source ↗

Summary

This entry notes a trial evaluating nafamostat mesylate for prognosis in sepsis-induced coagulopathy patients undergoing hemofiltration, with recruitment not ye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis-induced Coagulopathy

Drugs mentioned

• Nafamostat Mesylate (nafamostat)

Snippet

Sponsor: The First Hospital of Jilin University | Conditions: Sepsis-induced Coagulopathy (SIC) | NA | Status: NOT_YET_RECRUITING